2I19 image
Deposition Date 2006-08-13
Release Date 2006-10-17
Last Version Date 2023-08-30
Entry Detail
PDB ID:
2I19
Keywords:
Title:
T. Brucei farnesyl diphosphate synthase complexed with bisphosphonate
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.28 Å
R-Value Free:
0.24
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Farnesyl pyrophosphate synthase
Chain IDs:A, B
Chain Length:390
Number of Molecules:2
Biological Source:Trypanosoma brucei
Primary Citation
Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes.
J.Am.Chem.Soc. 128 14485 14497 (2006)
PMID: 17090032 DOI: 10.1021/ja061737c

Abstact

Bisphosphonates are a class of molecules in widespread use in treating bone resorption diseases and are also of interest as immunomodulators and anti-infectives. They function by inhibiting the enzyme farnesyl diphosphate synthase (FPPS), but the details of how these molecules bind are not fully understood. Here, we report the results of a solid-state (13)C, (15)N, and (31)P magic-angle sample spinning (MAS) NMR and quantum chemical investigation of several bisphosphonates, both as pure compounds and when bound to FPPS, to provide information about side-chain and phosphonate backbone protonation states when bound to the enzyme. We then used computational docking methods (with the charges assigned by NMR) to predict how several bisphosphonates bind to FPPS. Finally, we used X-ray crystallography to determine the structures of two potent bisphosphonate inhibitors, finding good agreement with the computational results, opening up the possibility of using the combination of NMR, quantum chemistry and molecular docking to facilitate the design of other, novel prenytransferase inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures